CERO THERAPEUTICS HOLDINGS, INC. Quarterly Accounts Payable, Current in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Cero Therapeutics Holdings, Inc. quarterly Accounts Payable, Current history and growth rate from Q4 2021 to Q3 2024.
  • Cero Therapeutics Holdings, Inc. Accounts Payable, Current for the quarter ending September 30, 2024 was $6.67M.
Accounts Payable, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.67M Sep 30, 2024 10-Q/A 2024-11-20
Q2 2024 $6.35M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $7.06M Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $1.67M Dec 31, 2023 10-Q/A 2024-11-20
Q3 2022 $710K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $163K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $121K Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $14.4K Dec 31, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.